AbbVie shares hit record high as key immunology drug set for exclusivity until 2037
By Christy Santhosh (Reuters) -AbbVie shares rose 4% to a record high on Thursday after...
Eli Lilly loses appeal of $183.7 million Medicaid fraud award
By Jonathan Stempel (Reuters) -A federal appeals court on Thursday rejected Eli Lilly’s appeal of...
Delta Air Lines reaffirms annual profit forecast on sustained travel demand
(Reuters) -Delta Air Lines on Thursday reaffirmed its full-year and current-quarter earnings forecasts, betting on...
Nvidia unveils AI chips for video, software generation
(Reuters) -Nvidia said on Tuesday it would launch a new artificial intelligence chip by the...
Hedge funds ride August highs to keep returns positive
(Clarifies timing of Goldman Sachs note which went to clients on September 2, not this...
Trump directed top aide to warn Qatar that Israel attack was coming, White House says
By Jeff Mason and Steve Holland WASHINGTON (Reuters) – U.S. President Donald Trump feels “very...
Citigroup CFO expects investment banking fees and market revenue to grow by mid-single digits in Q3
By Tatiana Bautzer NEW YORK (Reuters) – Citigroup Chief Financial Officer Mark Mason said at...
Exclusive-ASML becomes Mistral AI’s top shareholder after leading latest funding round, sources say
By Milana Vinn and Max A. Cherney NEW YORK -ASML, a crucial supplier of advanced...
US appeals court says Trump cannot continue foreign aid cuts
By Dietrich Knauth and Daniel Wiessner (Reuters) -A U.S. appeals court on Friday declined to...
OPEC+ set to raise oil output further from October, sources say
By Olesya Astakhova, Dmitry Zhdannikov and Ahmed Rasheed LONDON/MOSCOW/BAGHDAD (Reuters) -OPEC+ is set to agree...